Follicle rupture and release of the of the oocyte and associated cumulus granulosa cells, the cumulus-oocyte complex (COC), from the mural granulosa cell layer requires significant cellular reorganization and extracellular matrix (ECM) remodeling via the action of proteases. Moreover, loss of cell-cell contacts and formation of a hyaluronan-rich matrix between cumulus cells leads to an "expanded" COC (cumulus-oocyte expansion;C-OE) that can detach from the follicle wall. While follicle rupture and C-OE are known to be critical for fertility, the individual cellular events required for these processes have not been fully elucidated. A genomic study conducted by the Co-P.l.s (Drs. Stouffer and Hennebold) identified mRNAs whose levels increase through the periovulatory interval and are likely involved in ECM remodeling (e.g., proteases) and C-OE (e.g., prostaglandin synthesis and signaling components). Proof-of-principle studies revealed that COC release and expansion could be prevented by intrafollicular delivery of compounds that block metalloproteinase activity and prostaglandin E2 receptor (PTGER) subtype 2 signaling, respectively. Further analysis of the genomic database also revealed the presence of a gene target that is expressed selectively in the ovary and only during the periovulatory interval, suggesting a potential critical role for the encoded protein in ovulation. As part (Project ll) of the U54 CDRC application entitied "Contraception by Blockade of Periovulatory Events In Primates", proposed experiments will evaluate the potential for PTGER antagonists to prevent C-OE and serve as reversible contraceptives in fertile, female macaques, as well as to establish their pharmacokinetic and pharmacodynamic profiles in women (AIM 1);determine whether inhibiting the action of select proteases expressed preferentially in the primate follicle prevents its rupture (AIM 2), and evaluate the ability of specific inhibitors of ovary- and ovulation-selective gene products to block ovulation in rhesus macaques (AIM 3). Specific inhibitors/approaches that block individual metalloproteinases, PTGER signaling, and a select ovary-specific gene product (ACPP) will be tested for their ability to prevent follicle rupture and C-OE. Contraceptive potential and reversibility of C-OE inhibitors, e.g., PTGER antagonists, will be performed in the Nonhuman Primate Contraceptive Core, while preclinical trials involving women volunteers will be conducted to further define their safety and efficacy profiles. Collectively, these studies will establish the potential for inhibitors of ovulation/C-OE to serve as novel, non-hormonal methods of contraception in women.

Public Health Relevance

Current contraceptive methods feature failure rates, side effects, or other characteristics that limit their acceptance by some women, thus contributing to high rates of unintended pregnancy. The objective of this research, therefore, is to identify and develop non-hormonal contraceptives that directly block the release of the egg from the ovary, without affecting the systemic hormonal milieu or menstrual cyclicity.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD055744-08
Application #
8699799
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
City
Portland
State
OR
Country
United States
Zip Code
97239
Slayden, Ov D; Lee, Dong Ock; Yao, Shan et al. (2016) Polidocanol induced tubal occlusion in nonhuman primates: immunohistochemical detection of collagen I-V. Contraception 94:521-526
Jensen, Jeffrey T; Hanna, Carol; Yao, Shan et al. (2015) Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons. Contraception 92:96-102
Hanna, Carol B; Yao, Shan; Ramsey, Cathy M et al. (2015) Phosphodiesterase 3 (PDE3) inhibition with cilostazol does not block in vivo oocyte maturation in rhesus macaques (Macaca mulatta). Contraception 91:418-22
Peluffo, M C; Stanley, J; Braeuer, N et al. (2014) A prostaglandin E2 receptor antagonist prevents pregnancies during a preclinical contraceptive trial with female macaques. Hum Reprod 29:1400-12
Peluffo, Marina C; Hennebold, Jon D; Stouffer, Richard L et al. (2013) Oocyte maturation and in vitro hormone production in small antral follicles (SAFs) isolated from rhesus monkeys. J Assist Reprod Genet 30:353-9
Edelman, Alison B; Jensen, Jeffrey T; Doom, Carmen et al. (2013) Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women. Contraception 87:352-7
Stouffer, Richard L; Bishop, Cecily V; Bogan, Randy L et al. (2013) Endocrine and local control of the primate corpus luteum. Reprod Biol 13:259-71
Micks, Elizabeth; Shekell, Taylor; Stanley, Jessica et al. (2012) Medical termination of pregnancy in cynomolgus macaques. J Med Primatol 41:394-402
Keator, Christopher S; Mah, Kuni; Slayden, Ov D (2012) Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis. Mol Hum Reprod 18:308-19
Hanna, Carol B; Yao, Shan; Wu, Xuemei et al. (2012) Identification of phosphodiesterase 9A as a cyclic guanosine monophosphate-specific phosphodiesterase in germinal vesicle oocytes: a proposed role in the resumption of meiosis. Fertil Steril 98:487-95.e1

Showing the most recent 10 out of 23 publications